CD8A and neoplasm: The expression of OX40L by Delta-24-RGDOX-infected tumor cells led to the enhanced proliferation of CD8+ T cells recognizing TAAs compared to its predecessor DNX-2401, demonstrating the potential of this virus to induce more potent T cell-mediated immunity within a tumor [30,31].